Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC)

被引：0
|
作者：
Sarker, Debashis
Borek, Weronika E.
Pedicona, Federico
Zen, Yoh
Christopher, Josie A.
Karampera, Christina
Campbell, Amy
Khorsandi, Shirin Elizabeth
Dowe, Thomas
Habarwaa, Marwo
Britton, David James
Heaton, Nigel
Cutillas, Pedro Rodriguez
Williamson, Andrew
Dokal, Arran David
机构：
[1] Kings Coll Hosp London, Inst Liver Studies, London, England
[2] Kinomica Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2631
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
    Eso, Yuji
    Takeda, Haruhiko
    Taura, Kojiro
    Takai, Atsushi
    Takahashi, Ken
    Seno, Hiroshi
    CURRENT ONCOLOGY, 2021, 28 (05) : 4157 - 4166
  • [32] Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma
    Han, Ji Won
    Jang, Jeong Won
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [33] Therapy with Atezolizumab and Bevacizumab prolongs Life of Patients with hepatocellular Carcinoma
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
  • [34] ANALYSIS OF VARIX BLEEDING COMPLICATION AFTER ATEZOLIZUMAB PLUS BEVACIZUMAB FOR ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS
    Kim, Hee
    Lee, Ahlim
    Lee, Sung Won
    Lee, Haelim
    Kwon, Jung Hyun
    Kim, Chang Wook
    Cho, Se Hyun
    Nam, Heechul
    Yang, Hyun
    Song, Do Seon
    Chang, U. Im
    Nam, Soon Woo
    Lee, Soon Kyu
    Kim, Seok-Hwan
    Song, Myeong Jun
    Sung, Pil Soo
    Han, Ji Won
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jongyoung
    Yoon, Seung Kew
    HEPATOLOGY, 2024, 80
  • [35] Organ-specific responses to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma.
    Cheon, Jaekyung
    Jung, Sanghoon
    Kang, Beodeul
    Kim, Hyeyeong
    Kim, Chan
    Chon, Hongjae
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
    Yano, Yoshihiko
    Yamamoto, Atsushi
    Mimura, Takuya
    Kushida, Saeko
    Hirohata, Seiya
    Yoon, Seitetsu
    Hirano, Hirotaka
    Kim, Soo Ki
    Hatazawa, Yuri
    Momose, Kenji
    Hayashi, Hiroki
    Kado, Takuo
    Nishi, Katsuhisa
    Tanaka, Hidenori
    Matsuura, Takanori
    Yoshida, Ryutaro
    Asaji, Naoki
    Yasutomi, Eiichiro
    Shiomi, Yuuki
    Minami, Akihiro
    Komatsu, Shohei
    Fukumoto, Takumi
    Ueda, Yoshihide
    Kodama, Yuzo
    JGH OPEN, 2023, 7 (07): : 476 - 481
  • [37] Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma
    Kim, Hyung-Don
    Park, Young-Gyu
    Kim, Sejin
    Kim, Kyu-Pyo
    Park, Sook-Ryun
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Yoo, Changhoon
    HEPATOLOGY INTERNATIONAL, 2024, 18 (03) : 973 - 983
  • [38] Complete Metabolic Response by 18F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
    Uchida, Yoichiro
    Yoh, Tomoaki
    Fukui, Ayaka
    Takai, Atsushi
    Hatano, Etsuro
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (05) : 417 - 419
  • [39] Atezolizumab and bevacizumab for advanced hepatocellular carcinoma: a single centre real world experience
    Tan, Pei Ying
    Hui, Samuel
    O'Neill, Paul
    Dev, Anouk
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 142 - 143
  • [40] Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.
    Bezalel, Nomi
    Davidov, Yana
    Likhter, Mariya
    Ezra, Oranit Cohen
    Inbar, Yael
    Halpern, Naama
    Ben Boursi
    Beller, Tamar
    Pery, Ron
    Shmueli, Einat S.
    Nachmany, Ido
    Ben Ari, Ziv
    Margalit, Ofer
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345